Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000266134 | SCV000333409 | uncertain significance | not provided | 2018-05-23 | criteria provided, single submitter | clinical testing | |
Génétique des Maladies du Développement, |
RCV001004727 | SCV001164197 | likely pathogenic | Autosomal dominant nocturnal frontal lobe epilepsy 4 | 2018-02-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000266134 | SCV003930560 | uncertain significance | not provided | 2022-12-06 | criteria provided, single submitter | clinical testing | De novo variant with confirmed parentage in a patient referred for genetic testing at GeneDx; however, the reported clinical features are only partially consistent with the features typically observed in individuals with pathogenic variants in this gene; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |